Corinne E. Augelli-Szafran, Ph.D.
Director, Chemistry Department
Corinne E. Augelli-Szafran, Ph.D., is responsible for managing chemical research initiatives for the identification of new therapies in oncology, infectious diseases, diabetes, and neuroscience. Augelli-Szafran brings more than 25 years of practical and managerial experience in medicinal chemistry and drug discovery gained from leading research programs at institutions and pharmaceutical companies.
Prior to joining Southern Research, Augelli-Szafran was the director of the Laboratory for Experimental Alzheimer Drugs (LEAD) at Harvard Medical School and Brigham and Women’s Hospital in Boston. In that position, she built a fully functional medicinal chemistry and drug discovery laboratory from the ground up, which focused on the development of gamma-secretase Notch-sparing inhibitors for the therapeutic indication of Alzheimer’s disease.
Prior to Harvard, Augelli-Szafran held a number of leadership roles at Parke-Davis Pharmaceutical Research and Pfizer Global Research and Development. As co-chair and project leader, she investigated central nervous system therapeutics with a major emphasis in neurodegeneration, mainly in Alzheimer disease therapeutics, but also in the areas of cardiovascular, atherosclerosis, psychotherapeutics and inflammation and pain.
Her scientific record includes more than 140 publications, presentations and patents. She has been invited to speak worldwide on her academic drug discovery research, and she has consulted for various drug discovery efforts. Additionally, she was an active member of NIH study sections for several years, served as a faculty sponsor and mentor to Harvard students, was advisor to scientific meetings, and is currently a reviewer for several journals.
Augelli-Szafran is currently an adjunct professor in the Department of Chemistry at the University of Alabama, Birmingham, and she also serves as scientific chemistry coordinator for the NCI Chemical Biology Consortium (CBC). Most recently, she has become a member of the newly founded Center for Neuromolecular Research (CNR).
She received her Bachelor of Arts in biology from the University of Pennsylvania and her Master of Science and doctorate in organic chemistry from New York University.